AI assistant
LABCORP HOLDINGS INC. — Director's Dealing 2021
May 5, 2021
30237_dirs_2021-05-05_fa0217b1-85e1-4440-81fa-36e0faeeddc9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-05-03
Reporting Person: BELINGARD JEAN-LUC (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-03 | Common Stock | M | 2600 | $98.49 | Acquired | 18169 | Direct |
| 2021-05-03 | Common Stock | S | 2600 | $269.1551 | Disposed | 15569 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-03 | Non-qualified Stock Options | $98.49 | M | 2600 | Disposed | 2021-05-11 | Common Stock (2600) | Direct |
Footnotes
F1: The price of $269.1551 per share represents a weighted average of sales prices ranging from $269.06 to $269.291 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security
holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F2: Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
F3: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.